Cite
HARVARD Citation
de Jong, E. et al. (2022). Real‐world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocarcinoma. International journal of cancer. 150 (10), pp. 1654-1663. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
de Jong, E. et al. (2022). Real‐world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocarcinoma. International journal of cancer. 150 (10), pp. 1654-1663. [Online].